13F Pro quality score
Rank #648 of 2,925TOP 25%
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
AI-extracted from the 10-Q filed 2026-08-05 — Q2 FY2026 (quarter ended June 27, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Net sales grew 11.6% YoY to $7.7B, but net income fell 58.3% YoY to $139M as a $336M fire at the Tracy, California distribution center and a post-IPO effective tax rate jump to 40.9% offset revenue growth.
Driven by volume growth in Prime Vendor sales, including new relationship signings and growth with existing customers
Driven by volume growth in Prime Vendor sales, partially offset by $89M of customer repayments associated with tariff refunds
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Reported revenue, net income and operating margin by fiscal year, from Medline Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $28.4B | $1.2B | 7.8% |
| FY 2024 | 10-K | $25.5B | $1.2B | 8.4% |
| FY 2023 | 10-K | $23.2B | $234.0M | 5.4% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
Medline Inc. (MDLN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MDLN at 63.0/100 on a composite quality score built from its SEC filings, placing it at rank #648 of 2,925 stocks — the top 25% of the AI-ranked universe. MDLN scores in the top quartile across revenue scale (94.8), institutional flow (93.8), earnings quality (82.9). Based on the latest XBRL financial filings (Q2 2026), Medline Inc. reports quarterly revenue of $7.7B, net income of $139.0M, an operating margin of 5.1%. Top institutional holders of MDLN by reported 13-F value include Carlyle Group, Blackstone, H&F Corporate Investors X, Ltd., based on the most recent SEC filings. MDLN trades on the Nasdaq exchange and files with the SEC under CIK 2046386. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MDLN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Medline Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 2046386 →